Medical Physics Visiting Scientist from Chile at DKFZ

International Collaboration Advances Artificial Intelligence (AI) Research in Melanoma Detection at DKFZ

Dr. Cristóbal Lecaros from Clínica Alemana de Santiago de Chile (CAS) recently began a research visit at the German Cancer Research Center (DKFZ), joining the Division of Digital Prevention, Diagnostics and Therapy Guidance led by PD Dr. Titus Brinker. Working together with Dr. Kevin Allen, the main research project of the visit will be developing explainable artificial intelligence solutions for melanoma detection.

The research team is specifically working on extending AI techniques for the histopathological differential diagnosis of melanoma, a potentially lethal form of skin cancer. This project represents a crucial advancement in the field of digital dermatology, where AI tools are being carefully implemented to support healthcare delivery while maintaining high standards of safety and explainability.

This international collaboration addresses a critical aspect of AI implementation in healthcare: the need for fairness and bias mitigation in algorithm development. By bringing together regional experts from DKFZ with Latin America researchers, the team ensures that technological solutions are developed with contextual awareness, making them more applicable and effective across different healthcare settings.

The partnership highlights the growing importance of international cooperation in developing AI healthcare solutions that are not only technically innovative but also ethically sound and globally applicable. Through such collaborations, the team aims to advance the field while ensuring that AI tools are developed and implemented in ways that benefit all populations equitably.